...
首页> 外文期刊>Clinical and experimental pharmacology & physiology >Retracted: ‘Anti‐fibrotic actions of Ghrelin by inhibition of the NADPH oxidase–ROS signaling pathway’ by Qian Wang, Xin Sui, Rui Chen, Peiyong Ma, Tao Ding, Dianjun Sui, and Ping Yang
【24h】

Retracted: ‘Anti‐fibrotic actions of Ghrelin by inhibition of the NADPH oxidase–ROS signaling pathway’ by Qian Wang, Xin Sui, Rui Chen, Peiyong Ma, Tao Ding, Dianjun Sui, and Ping Yang

机译:Retracted: ‘Anti‐fibrotic actions of Ghrelin by inhibition of the NADPH oxidase–ROS signaling pathway’ by Qian Wang, Xin Sui, Rui Chen, Peiyong Ma, Tao Ding, Dianjun Sui, and Ping Yang

获取原文
获取原文并翻译 | 示例
           

摘要

The above article, published online on 17 April 2018 in Wiley Online Library ( wileyonlinelibrary.com ), has been withdrawn by agreement between the authors, the journal Editor in Chief, Prof. Jun‐Ping Liu, and John Wiley & Sons, Ltd. The authors have withdrawn the paper due to the lack of reproducibility of some of the findings reported in the paper during the consequent experimental work (in particular, the numeric data related to the levels of proteins involved into or responsive to induction of NADPH oxidase pathway). Although these discrepancies do not affect the major conclusions of the paper, the possible presence of incorrect experimental data requires serious revision of the manuscript and thus necessitates the withdrawal of the article. Reference Wang Q , Sui X , Chen R , et al. Anti‐fibrotic actions of Ghrelin by inhibition of the NADPH oxidase–ROS signalling pathway . Clin Exp Pharmacol Physiol 2018 ; 00 : 1 ‐ 14 . https://doi.org/10.1111/1440-1681.12948
机译:None

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号